Daniella Beckman - Insider Trading & Ownership

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., One Kendall Square, Bldg. 1400, Cambridge, MA
Summary
The estimated net worth of Daniella Beckman is at least $2.88M dollars as of October 15, 2024. Daniella Beckman is the Chief Financial Officer of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $1.67M. Daniella Beckman is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $1.21M.
All Insider Reports
All Insider Reports

Ownership of Daniella Beckman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TNGX Tango Therapeutics, Inc. Chief Financial Officer $1.67M -$46.9K -2.73% Feb 6, 2024
BPMC Blueprint Medicines Corp Director $1.21M Jun 12, 2024
TBIO Translate Bio, Inc. Director Sep 14, 2021
UPB Upstream Bio, Inc. Director Oct 10, 2024
VOR Vor Biopharma Inc. Director May 23, 2024

Insider Transactions Reported by Daniella Beckman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.